Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Cancer mutation prediction using artificial intelligence

Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA

Cancer mutation prediction using artificial intelligence ( Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA )

No OS improvement over chemo from capivasertib plus paclitaxel in advanced TNBC

Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA

No OS improvement over chemo from capivasertib plus paclitaxel in advanced TNBC ( Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA )

Mutational-based treatment approach may significantly improve outcomes in...

Dr Andrea Botticelli - Sapienza Università di Roma, Rome, Italy

Mutational-based treatment approach may significantly improve outcomes in pretreated patients with metastatic solid tumours ( Dr Andrea Botticelli - Sapienza Università di Roma, Rome, Italy )

Mirvetuximab soravtansine shows promise in FRα-positive, platinum-sensitive...

Dr Angeles Alvarez Secord - Duke Cancer Center, Durham, USA

Mirvetuximab soravtansine shows promise in FRα-positive, platinum-sensitive ovarian cancer ( Dr Angeles Alvarez Secord - Duke Cancer Center, Durham, USA )

ESMO 2024: Latest in EGFR mutated NSCLC

Prof Ignacio Gil-Bazo, Dr Mariana Brandão, Prof Benjamin Besse and Prof...

ESMO 2024: Latest in EGFR mutated NSCLC ( Prof Ignacio Gil-Bazo, Dr Mariana Brandão, Prof Benjamin Besse and Prof Enriqueta Felip )

Improved structure preservation with neo-adjuvant platinum-based chemo in...

Prof Nabil F. Saba - Winship Cancer Institute of Emory University, Atlanta, USA

Improved structure preservation with neo-adjuvant platinum-based chemo in patients with resectable NPNSCC ( Prof Nabil F. Saba - Winship Cancer Institute of Emory University, Atlanta, USA )

Retifanlimab plus chemo shows PFS benefit in recurrent or metastatic squamous...

Dr Sheela Rao - The Royal Marsden, London, UK

Retifanlimab plus chemo shows PFS benefit in recurrent or metastatic squamous cell carcinoma of the anal canal ( Dr Sheela Rao - The Royal Marsden, London, UK )

TNBC: Neoadjuvant pembrolizumab plus chemo followed by adjuvant pembrolizumab...

Prof Peter Schmid - Barts Cancer Institute, London, UK

TNBC: Neoadjuvant pembrolizumab plus chemo followed by adjuvant pembrolizumab shows improvement in OS compared to neoadjuvant chemo alone ( Prof Peter Schmid - Barts Cancer Institute, London, UK )

ESMO 2024: Latest updates in mRCC

Dr Javier Puente, Dr Guillermo De Velasco, Dr Cristina Suárez and Prof Stéphane...

ESMO 2024: Latest updates in mRCC ( Dr Javier Puente, Dr Guillermo De Velasco, Dr Cristina Suárez and Prof Stéphane Oudard )

Understanding the use of PARPi combinations to treat patients with mCRPC

Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof...

Understanding the use of PARPi combinations to treat patients with mCRPC ( Prof Axel Merseburger, Dr Friederike Schlurmann, Dr Elena Castro and Prof Gerhardt Attard )

Enzalutamide treatment boosted by Radium-223 in mCRPC

Prof Silke Gillessen - Oncology Institute of Southern Switzerland, Bellinzona...

Enzalutamide treatment boosted by Radium-223 in mCRPC ( Prof Silke Gillessen - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland )

TACE combined with lenvatinib-pembrolizumab shows improved PFS in intermediate...

Prof Josep Llovet - Hospital Clinic Barcelona, Barcelona, Spain

TACE combined with lenvatinib-pembrolizumab shows improved PFS in intermediate stage liver cancer ( Prof Josep Llovet - Hospital Clinic Barcelona, Barcelona, Spain )

More from ecancer